BioCryst was founded in 1986 and completed its Initial Public Offering in March 1994. The Company's stock is traded on the NASDAQ exchange under the symbol BCRX.
Please refer to the Company's most recent filings with the Securities and Exchange Commission on Forms 10-Q/10-K for the latest published financial information.
BioCryst's fiscal year ends December 31st.
BioCryst releases quarterly earnings following the end of each quarter. You may visit our Investor Relations section and submit your email to receive future BioCryst press releases announcing these calls and other events.
Visit our "Information Request" page to submit your mailing and contact details or click here.
Contact your local financial representative.
American Stock Transfer & Trust Company
59 Maiden Lane
New York, NY 10038
1-800-937-5449 (toll free in US and Canada)
1-718-921-8200 (callers outside the US and Canada)
Please submit your question using the form below.